March 29, 2026 - An Australian hemp company, GreenWave Naturals, has unveiled a new line of CBD-infused beverages, marking a significant entry into the competitive functional drinks market. The launch, announced earlier this week, includes a range of sparkling waters and teas infused with broad-spectrum CBD, targeting health-conscious consumers seeking alternatives to traditional energy drinks and sodas.
What Sets This Product Line Apart
GreenWave Naturals’ beverages stand out due to their emphasis on sustainability and local sourcing. The company claims to use hemp grown exclusively on Australian farms, adhering to strict organic standards. Each drink contains 10-20 mg of CBD per serving, with flavors like citrus-mint and berry-ginger designed to appeal to a broad audience. Additionally, the products are marketed as non-intoxicating and free of THC, aligning with Australia’s stringent regulations on cannabis-derived products.
“We wanted to create a product that not only offers the potential calming benefits associated with CBD but also reflects our commitment to environmental responsibility,” said GreenWave CEO Sarah Thompson in a press statement. The company has also partnered with a local recycling initiative to ensure that packaging materials are fully recyclable.
Market Context and Consumer Trends
The global CBD beverage market has seen rapid growth in recent years, driven by increasing consumer interest in wellness-focused products. In Australia, where CBD products are tightly regulated and only available through specific channels, GreenWave’s launch represents a bold move to capture a share of this emerging niche. According to market analysts, the Asia-Pacific region is expected to see a surge in demand for CBD-infused drinks as regulatory barriers gradually ease and public awareness grows.
However, GreenWave faces stiff competition from both domestic and international brands. Established players in the U.S. and Canada have already begun exporting CBD beverages to Australia, leveraging their experience in formulation and branding. GreenWave’s focus on local production could give it an edge in terms of freshness and cultural resonance, but scaling up to meet demand will be a key challenge.
Regulatory Landscape in Australia
Australia’s Therapeutic Goods Administration (TGA) downgraded low-dose CBD to a Schedule 3 substance in 2021, allowing over-the-counter sales under strict conditions. However, the market remains heavily monitored, with companies required to provide detailed safety and quality data for their products. GreenWave has stated that its beverages comply with all TGA guidelines, including third-party testing for purity and potency.
Still, navigating this regulatory environment is no small feat. Any misstep in labeling or marketing could result in penalties or product recalls, a risk that has deterred some smaller companies from entering the space. GreenWave’s ability to maintain compliance while building brand trust will be critical to its success.
Implications for the Global Industry
GreenWave Naturals’ launch highlights the growing internationalization of the CBD beverage sector. As more countries refine their regulations around hemp-derived products, companies are racing to establish footholds in untapped markets. For Australia, this could signal the beginning of a broader acceptance of CBD-infused consumables, potentially paving the way for other innovations in food and drink.
For now, GreenWave’s products are available through select retailers and online platforms in Australia, with plans for expansion into New Zealand by late 2026. Industry observers will be watching closely to see how consumers respond and whether this launch inspires similar ventures in the region. CBDChamp will continue to report on this developing story as GreenWave Naturals seeks to make waves in the global CBD market.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.